Invivo Therapeutics Holdings Corp.

CIK 1292519 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Invivo Therapeutics Holdings Corp..

Recent SEC filings

FiledFormAccession number
Mar 21, 202425-NSE0001354457-24-000196
Feb 14, 2024SC 13G/A0001172661-24-001281
Feb 13, 2024SC 13G/A0000929638-24-000571
Feb 7, 202440001974830-24-000001
Feb 7, 20244/A0001974830-24-000002
Feb 6, 20248-K0001104659-24-010941
Feb 6, 2024SC 13G/A0001085146-24-000754
Feb 1, 20248-K0001104659-24-009146
Jan 3, 20248-K0001104659-24-000868
Dec 5, 2023ARS0001104659-23-123477
Dec 5, 2023DEF 14A0001104659-23-123476
Dec 1, 20238-K0001104659-23-122862
Nov 30, 20238-K0001104659-23-122271
Nov 22, 20238-K0001104659-23-120778
Nov 8, 202310-Q0001558370-23-018294
Sep 1, 20238-K0001104659-23-097791
Aug 9, 202310-Q0001558370-23-014294
May 12, 202310-Q0001558370-23-009616
Apr 25, 2023SC 13G0001085146-23-001868
Apr 24, 202330001974830-23-000002
Mar 9, 20238-K0001104659-23-030358
Mar 1, 202310-K0001558370-23-002588
Feb 14, 2023SC 13G0001172661-23-001143
Feb 13, 2023SC 13G/A0000929638-23-000407
Nov 21, 202240001104659-22-120828